Not less than-95.0%
6β-Hydroxylevonorgestrel; (6β,17α)-13-Ethyl-6,17-dihydroxy-18,19-dinorpregn-4-en-20-yn-3-one; 6β-Hydroxy analog; 13-Ethyl-6β,17-dihydroxy-18,19-dinor-17α-pregn-4-en-20-yn-3-one (As per USP Commenting Opening 51(3));